XOMAO

BEARISH

$25.54 Live

XOMA Royalty Corporation · NASDAQ

$24.86 52W Range $26.4

XOMAO XOMA Royalty Corporation - Fundamental Analysis

BEARISH

Console Chart News

XOMAO Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Biotechnology

Current Price Live

$25.54

52W High

$26.4

52W Low

$24.86

Overview AI Snowflake Price Valuation Profitability Growth Health Statements

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 24, 2026

Market cap

N/A

P/E

25.51

ROE

34.1%

Profit margin

60.8%

Debt/Equity

1.27

Dividend yield

8.2%

AI Analysis

AI-powered fundamental assessment

Confidence

85%

XOMAO exhibits severe valuation misalignment, trading at $25.54 despite a Graham Number of $12.62 and an Intrinsic Value of $7.01. The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating fundamental strength. While the company boasts exceptional profit margins (60.81%) and ROE (34.12%), these are offset by a bearish technical trend (0/100) and negative Q/Q revenue growth. The high dividend yield of 8.2% appears risky given the low dividend strength score and overall fundamental weakness.

Key Strengths

Exceptional profit margins (60.81%)

Strong Return on Equity (34.12%)

Robust liquidity with a Current Ratio of 3.37

Strong Year-over-Year revenue growth (57.90%)

High dividend yield (8.20%)

Key Risks

Significant overvaluation relative to Graham and Intrinsic values

Weak fundamental health (Piotroski F-Score 3/9)

Bearish technical momentum (0/100 trend score)

Sharp decline in Q/Q revenue growth (-38.86%)

Low insider sentiment (40/100)

AI Fair Value Estimate

Based on comprehensive analysis

$12.62

-50.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Moderate

Value

Future

Past

Health

Dividend

AI Verdict

Overvalued & Fundamentally Weak

Key drivers: Extreme valuation premium, Low Piotroski F-Score, Bearish technicals

Confidence

90%

Value

20/100

Ref P/E 25.51, Graham Number $12.62

Positives

P/E is lower than the sector average

Watchpoints

Price is ~2x the Graham Number
Price is ~3.6x the Intrinsic Value

Future

45/100

Ref Growth rates and Technical Trend

Positives

Strong YoY revenue growth

Watchpoints

Negative Q/Q revenue growth
Bearish technical trend

Past

60/100

Ref Historical price changes

Positives

Positive 5Y and 3Y price performance

Watchpoints

Recent momentum has stalled

Health

30/100

Ref Piotroski F-Score

Positives

High Current Ratio (3.37)

Watchpoints

Piotroski F-Score of 3/9 (Weak)
Debt/Equity of 1.27

Dividend

50/100

Ref Yield and Dividend Strength

Positives

High yield of 8.20%

Watchpoints

Low dividend strength score (40/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$25.54

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for XOMAO and closest competitors.

Updated 2026-04-23

Company	5Y	3Y	1Y	6M	1M	1W
XOMAO XOMA Royalty Corporation Primary	+57.3%	+35.5%	+9.6%	+4.3%	+2.6%	-0.2%

XOM

XOMA Royalty Corporation

Primary

+57.3%

+35.5%

+9.6%

+4.3%

+2.6%

-0.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

25.51

N/A

3.61

N/A

7.14

25.94

N/A

Profitability

Profit margins and return metrics

Profit Margin 60.81%

Operating Margin 15.86%

Gross Margin 96.72%

ROE 34.12%

ROA 2.88%

Growth

Revenue and earnings growth rates

Revenue Growth +57.9%

Earnings Growth N/A

Q/Q Revenue Growth -38.86%

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

1.27

Moderate

Current Ratio

3.37

Strong

Quick Ratio

3.19

Excellent

Cash/Share

$7.0

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue

$0.0B

Op. Margin

152.4%

Net Margin

426.2%

Total Assets

$0.3B

Liabilities

$0.2B

Equity

$0.1B

Debt/Equity

2.25x

Operating CF

$-0.0B

Free Cash Flow

$-0.0B

FCF Yield

100%

Healthcare Sector Comparison

Comparing XOMAO against 528 companies in the Healthcare sector (28 bullish, 156 neutral, 344 bearish)

P/E Ratio

25.51

This Stock

81.62

Sector Avg

-68.7% (Discount)

Return on Equity (ROE)

34.12%

This Stock

-92.94%

Sector Avg

-136.7% (Below Avg)

Profit Margin

60.81%

This Stock

-16.56%

Sector Avg

-467.3% (Weaker)

Debt to Equity

1.27

This Stock

2.75

Sector Avg

-54.0% (Less Debt)

Revenue Growth

57.9%

This Stock

131.76%

Sector Avg

-56.1% (Slower)

Current Ratio

3.37

This Stock

4.62

Sector Avg

-27.1% (Weaker)

Past News Coverage

Recent headlines mentioning XOMAO from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

XOMAO

XOMAO XOMA Royalty Corporation - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Healthcare Sector Comparison

Past News Coverage

Wait — Don't Miss Out!